— Know what they know.
Not Investment Advice

EVH NYSE

Evolent Health, Inc.
1W: -6.3% 1M: +23.9% 3M: +37.6% YTD: -1.3% 1Y: -56.2% 3Y: -88.7% 5Y: -80.8%
$3.95
+0.11 (+2.86%)
After Hours: $4.00 (+0.04, +1.14%)
Weekly Expected Move ±11.2%
$3 $4 $4 $4 $5
NYSE · Healthcare · Medical - Healthcare Information Services · Alpha Radar Neutral · Power 56 · $444.3M mcap · 102M float · 3.10% daily turnover · Short 39% of daily vol

Cash Flow Trends

Operating Cash Flow
$39M +107.0% ▲
Capital Expenditures
$34M -36.9% ▼
5Y CAGR: +3.0%
Free Cash Flow
$5M +177.6% ▲
Dividends Paid
$11M +44.6% ▲
Buybacks
$40M +0.0% ▲
Net Change in Cash
$14M +132.2% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$38M-$19M-$113M-$62M-$579M
Depreciation & Amort.$60M$67M$123M$126M$123M
Stock-Based Comp.$17M$34M$41M$40M$40M
Change in Working Capital-$22M-$104M$22M-$117M-$57M
Other Non-Cash Items$23M$11M$101M$34M$516M
Operating Cash Flow$39M-$12M$143M$19M$39M
— Investing Activities —
Capital Expenditures-$25M-$38M-$29M-$25M-$34M
Acquisitions (Net)$14M$6M$870K$0$0
Investment Purchases-$3M-$6M$0-$7M-$1M
Investment Sales$500K$6M$0$0$0
Other Investing-$3M-$226M-$388M-$31M$35M
Investing Cash Flow-$16M-$259M-$416M-$63M-$233K
— Financing Activities —
Net Debt Issuance-$38M$220M$183M$59M$65M
Stock Repurchased$0-$18M$0$0-$40M
Dividends Paid-$1M$0-$19M-$20M-$11M
Other Financing$9M-$70M-$51M-$43M-$50M
Financing Cash Flow-$30M$132M$281M-$565K-$36M
Net Change in Cash-$7M-$140M$8M-$45M$14M
Cash End of Period$355M$215M$223M$178M$178M
Free Cash Flow$14M-$50M$114M-$6M$5M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms